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Background: The National Institute for Health and care Excellence (NICE) has recently issued 
recommendations on the care of people with motor neurone disease (MND), promoting tailored 
care for each patient, Guideline 42, 2016. Previous studies suggest remote monitoring offers a 
facility to regularly monitor and interact with patients, providing timely interventions so it may 
facilitate delivery of the recommendations. The efficacy of this approach is dependent upon 
acceptability of telemonitoring to patients.  
Aim: To understand the experiences of using telemonitoring in ventilated patients with MND.  
Methods: Semi-structured interviews were conducted with seven patients (male=5; mean 
age=63yrs). The median illness duration was 14m (range=7m-13yrs 7m) and the median non-invasive 
ventilation (NIV) usage was 12m (range=0m-3yrs). Participants used a telemonitoring device 
(Docobo CAREPORTAL®) for six months, completed weekly nocturnal pulse oximetry and symptom-
related questions. Five caregivers were present at the interviews and provided their feedback. 
Interviews were audio recorded and transcribed verbatim. Thematic analysis was conducted to find 
overarching themes. The interpretation was reviewed and supported by a multidisciplinary team 
examination.  
Findings:  Five themes were identified: Technical Challenges, Increased Self-Awareness, Taking 
Initiative, Benefits of Timely Intervention, and Reducing the Unnecessary. Whilst participants 
expressed general ease of Careportal® use, technical issues included; messaging system challenges, 
oximetry transmission, device fault, mobile signal loss. No other negative experience of using 
Careportal® was reported. Overall, participants expressed how telemonitoring enabled symptom 
awareness and interpretation. The device also enabled the participants to raise their concerns 
and/or requests to the healthcare professionals via the messaging system, and this was depicted as a 
sharp contrast to current communication with hospitals. Timely interventions were observed as a 
result of regular monitoring, contributing to both physical and psychological well-being of the 
participants. It was also suggested that using Careportal® could reduce unnecessary cost/time and 
hassles created by attending hospital appointments.  
Conclusions: Telemonitoring enabled participants to be actively involved in their care and they felt 
that the interventions were timely delivered to meet their needs. The findings suggest potential 
benefits of utilising Careportal ® in routine care as a contact point to accommodate different 
individual’s needs.  
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